Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Moberg Analytics develops the Moberg Clinical Platform (MCP), software that aggregates and analyzes high-resolution multimodal neuromonitoring data from disparate ICU devices into near real-time insights. It serves clinicians and researchers in neurocritical care, particularly the neuro ICU and severe TBI treatment.
0 investors
Modulate Bio develops small-molecule GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety. Its drug-discovery platform aims to selectively activate specific GABAA receptor subunits to provide efficacy while limiting side effects.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Moleculin Biotech is a Phase 3 clinical-stage biopharmaceutical company developing therapeutic candidates for hard-to-treat tumors and viruses, with a lead program (Annamycin) targeting relapsed or refractory acute myeloid leukemia and soft tissue sarcoma.
0 investors
0 investors
0 investors
Mongoose Bio is a company focused on T-cell therapies for cancer, drawing on research into antigen-specific CD8+ T cells, IL-21 priming, and adoptive cell transfer for tumors such as melanoma and Merkel cell carcinoma.
0 investors
Monod Bio is a University of Washington spin-out that uses AI-powered de novo protein design to develop research-use-only tools and in vitro diagnostics. It operates in the life sciences and medical diagnostics sector.
0 investors
Monopar Therapeutics is a clinical-stage biotechnology company developing radiopharmaceuticals for oncology imaging and treatment of advanced solid tumors, along with ALXN1840, a late-stage investigational treatment for Wilson Disease, a rare genetic disorder. It advances its pipeline through in-house development and licensing of late-preclinical and clinical-stage therapeutics.
0 investors
0 investors
Morphoceuticals is a TechBio company mapping the "bioelectrome" — the body's cellular communication networks that govern tissue repair and organ regeneration. It combines multi-omics, bioelectric profiling, and AI to modulate ion channels for applications in regenerative medicine.
0 investors
0 investors
Most Cardio develops cardiovascular surgical instrumentation using a reposable design platform (reusable handles with disposable end effectors) combined with micro-robotics and nanotechnology to emulsify and remove arterial plaque via minimally invasive procedures. Its products, including a robotic control station, catheters, micro-emulsifiers, extractor wires and MIS access ports, target clinicians at hospitals and surgery centers as alternatives to stents, angioplasty and heart bypass surgery.
0 investors
Motley Bio is a Silicon Valley company applying multiomics analysis to the study of disease at early stages. Its work is directed at identifying the biological changes that precede clinical symptoms, for use in research and diagnostics.
0 investors
0 investors
0 investors
Mulberry Biotherapeutics develops bacteria-mediated immunotherapies using genetically engineered, live-attenuated Salmonella Typhimurium injected directly into tumors to treat rare, slow-growing tumors. Its lead program, MUL001, targets Neurofibromatosis type 2-related schwannomatosis (NF2-SWN), with planned follow-on indications including NF1-associated nerve sheath tumors and meningiomas.
0 investors